Medicine
 |
|
27 february 2020 20:02:55 |
| Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial (BMC Public Health) |
|
Tweet Human papillomavirus (HPV) is one of the most significant risk factors for cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical cancer. The present study aimed to investi... |
| 163 viewsCategory: Medicine |
 Who can we reach and who can we keep? Predictors of intervention engagement and adherence in a cluster randomized controlled trial in South Africa (BMC Public Health)Facilitators and barriers of managing patients with multiple chronic conditions in the community: a qualitative study (BMC Public Health) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
